Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
February 16, 2024 08:00 ET
|
Hepion Pharmaceuticals, Inc.
EDISON, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on artificial intelligence assisted therapeutic drug...
Canadian North Resources Receives $2,155,794 from Exercise of Warrants from Major Shareholders
December 14, 2023 08:30 ET
|
Canadian North Resources Inc.
TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Canadian North Resources Inc. ("the Company," TSXV: CNRI; OTCQX: CNRSF; FSE: EO0 (E-O-zero)) is pleased to announce that KRE Development Co. Ltd ("KRE"),...
Canadian North Resources Receives $2,155,797 from Early Exercise of Warrants from Major Shareholders
July 05, 2023 07:00 ET
|
Canadian North Resources Inc.
TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Canadian North Resources Inc. ("the Company," TSXV: CNRI; OTCQX: CNRSF; FSE: EO0 (E-O-zero)) is pleased to announce that KRE Development Co. Ltd ("KRE"),...
Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants
March 06, 2020 08:05 ET
|
Guardion Health Sciences, Inc.
San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates,...